Pandemic Darlings The pandemic economy, in original documents
Home Source documents Fulgent Genetics, Inc. Form 4 — BOLGER JOHN C (Aug. 30, 2021)Search ⌕

Fulgent Genetics, Inc. Form 4 — BOLGER JOHN C (Aug. 30, 2021)

Summary

BOLGER JOHN C, a director of Fulgent Genetics, Inc., reports on this Form 4 Stock Option (Right to Buy) exercises on 08/30/2021 of 312 shares at each of the exercise prices $3.925, $5.8098 and $15.82. Each exercise was paired with a sale of 312 shares the same day, at $91.3806, $91.442 and $91.054, and the reporting person owned 2,000 shares directly after each sale. Following the exercises the options covered 938, 2,188 and 3,438 shares, with expiration dates of 05/18/2028, 05/30/2029 and 05/26/2030. The explanation of responses says each option vests over a period of four years, subject to continued service for the Issuer; the remarks show /s/ Paul Kim, as Attorney-in-fact, dated 09/01/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Fulgent Genetics, Inc. Form 4 — BOLGER JOHN C (Aug. 30, 2021).” Original at www.sec.gov. Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/sec-flgt-4-filed2021-09-01-0001209191-21-054292-296c42af28/, SHA-256 ae79be73ecfe8b3297d9c047dd99dc1400fc97e8f86e4ab4e89a093d3ccfe0c9.

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * BOLGER JOHN C (Last) (First) (Middle) C/O FULGENT GENETICS, INC. 4978 SANTA ANITA AVE. (Street) TEMPLE CITY CA 91780 (City) (State) (Zip) | BOLGER JOHN C | (Last) | (First) | (Middle) | C/O FULGENT GENETICS, INC. | 4978 SANTA ANITA AVE. | TEMPLE CITY | CA | 91780 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Fulgent Genetics, Inc. [ FLGT ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) | X | Director | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 08/30/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 08/30/2021 | M | 312 | A | $ 3.925 | 2,312 | D
Common Stock | 08/30/2021 | S | 312 | D | $ 91.3806 | 2,000 | D
Common Stock | 08/30/2021 | M | 312 | A | $ 15.82 | 2,312 | D
Common Stock | 08/30/2021 | S | 312 | D | $ 91.054 | 2,000 | D
Common Stock | 08/30/2021 | M | 312 | A | $ 5.8098 | 2,312 | D
Common Stock | 08/30/2021 | S | 312 | D | $ 91.442 | 2,000 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Stock Option (Right to Buy) | $ 3.925 | 08/30/2021 | M | 312 | (1) | 05/18/2028 | Common Stock | 312 | $ 0.00 | 938 | D
Stock Option (Right to Buy) | $ 5.8098 | 08/30/2021 | M | 312 | (2) | 05/30/2029 | Common Stock | 312 | $ 0.00 | 2,188 | D
Stock Option (Right to Buy) | $ 15.82 | 08/30/2021 | M | 312 | (3) | 05/26/2030 | Common Stock | 312 | $ 0.00 | 3,438 | D
Explanation of Responses:
1. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
2. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
3. The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
Remarks:
/s/ Paul Kim, as Attorney-in-fact | 09/01/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File
SEC_FLGT_4_filed2021-09-01_0001209191-21-054292.xml
Size
22,363 bytes
SHA-256
ae79be73ecfe8b3297d9c047dd99dc1400fc97e8f86e4ab4e89a093d3ccfe0c9
Our copy
SEC_FLGT_4_filed2021-09-01_0001209191-21-054292.xml
Original
www.sec.gov
Back to top